Pharmacyte Biotech Stock Technical Analysis
| PMCB Stock | USD 0.72 0.06 7.69% |
As of the 12th of February 2026, PharmaCyte Biotech holds the Coefficient Of Variation of 6717.52, risk adjusted performance of 0.021, and Semi Deviation of 5.55. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PharmaCyte Biotech, as well as the relationship between them.
PharmaCyte Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as PharmaCyte, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PharmaCytePharmaCyte | Build AI portfolio with PharmaCyte Stock |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PharmaCyte Biotech. Anticipated expansion of PharmaCyte directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive PharmaCyte Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding PharmaCyte Biotech requires distinguishing between market price and book value, where the latter reflects PharmaCyte's accounting equity. The concept of intrinsic value - what PharmaCyte Biotech's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push PharmaCyte Biotech's price substantially above or below its fundamental value.
It's important to distinguish between PharmaCyte Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PharmaCyte Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PharmaCyte Biotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
PharmaCyte Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PharmaCyte Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PharmaCyte Biotech.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in PharmaCyte Biotech on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding PharmaCyte Biotech or generate 0.0% return on investment in PharmaCyte Biotech over 90 days. PharmaCyte Biotech is related to or competes with Quoin Pharmaceuticals, NovaBay Pharmaceuticals, Alaunos Therapeutics, VivoSim Labs, Impact BioMedical, Pasithea Therapeutics, and Polyrizon. PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for canc... More
PharmaCyte Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PharmaCyte Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PharmaCyte Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.6 | |||
| Information Ratio | 0.0041 | |||
| Maximum Drawdown | 68.81 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 7.79 |
PharmaCyte Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PharmaCyte Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PharmaCyte Biotech's standard deviation. In reality, there are many statistical measures that can use PharmaCyte Biotech historical prices to predict the future PharmaCyte Biotech's volatility.| Risk Adjusted Performance | 0.021 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (1.00) | |||
| Sortino Ratio | 0.0059 | |||
| Treynor Ratio | 0.05 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PharmaCyte Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PharmaCyte Biotech February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.021 | |||
| Market Risk Adjusted Performance | 0.06 | |||
| Mean Deviation | 5.11 | |||
| Semi Deviation | 5.55 | |||
| Downside Deviation | 6.6 | |||
| Coefficient Of Variation | 6717.52 | |||
| Standard Deviation | 9.58 | |||
| Variance | 91.82 | |||
| Information Ratio | 0.0041 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (1.00) | |||
| Sortino Ratio | 0.0059 | |||
| Treynor Ratio | 0.05 | |||
| Maximum Drawdown | 68.81 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 7.79 | |||
| Downside Variance | 43.56 | |||
| Semi Variance | 30.8 | |||
| Expected Short fall | (6.38) | |||
| Skewness | 3.75 | |||
| Kurtosis | 19.06 |
PharmaCyte Biotech Backtested Returns
PharmaCyte Biotech appears to be out of control, given 3 months investment horizon. PharmaCyte Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0253, which implies the firm had a 0.0253 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for PharmaCyte Biotech, which you can use to evaluate the volatility of the company. Please evaluate PharmaCyte Biotech's Semi Deviation of 5.55, risk adjusted performance of 0.021, and Coefficient Of Variation of 6717.52 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, PharmaCyte Biotech holds a performance score of 2. The company holds a Beta of 2.65, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PharmaCyte Biotech will likely underperform. Please check PharmaCyte Biotech's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether PharmaCyte Biotech's historical price patterns will revert.
Auto-correlation | 0.53 |
Modest predictability
PharmaCyte Biotech has modest predictability. Overlapping area represents the amount of predictability between PharmaCyte Biotech time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PharmaCyte Biotech price movement. The serial correlation of 0.53 indicates that about 53.0% of current PharmaCyte Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.53 | |
| Spearman Rank Test | -0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
PharmaCyte Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
PharmaCyte Biotech Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for PharmaCyte Biotech across different markets.
About PharmaCyte Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of PharmaCyte Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of PharmaCyte Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on PharmaCyte Biotech price pattern first instead of the macroeconomic environment surrounding PharmaCyte Biotech. By analyzing PharmaCyte Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of PharmaCyte Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to PharmaCyte Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2011 | 2025 (projected) | Dividend Yield | 0.12 | 0.11 | Price To Sales Ratio | 215.39 | 3.2K |
PharmaCyte Biotech February 12, 2026 Technical Indicators
Most technical analysis of PharmaCyte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for PharmaCyte from various momentum indicators to cycle indicators. When you analyze PharmaCyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.021 | |||
| Market Risk Adjusted Performance | 0.06 | |||
| Mean Deviation | 5.11 | |||
| Semi Deviation | 5.55 | |||
| Downside Deviation | 6.6 | |||
| Coefficient Of Variation | 6717.52 | |||
| Standard Deviation | 9.58 | |||
| Variance | 91.82 | |||
| Information Ratio | 0.0041 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (1.00) | |||
| Sortino Ratio | 0.0059 | |||
| Treynor Ratio | 0.05 | |||
| Maximum Drawdown | 68.81 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 7.79 | |||
| Downside Variance | 43.56 | |||
| Semi Variance | 30.8 | |||
| Expected Short fall | (6.38) | |||
| Skewness | 3.75 | |||
| Kurtosis | 19.06 |
PharmaCyte Biotech February 12, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as PharmaCyte stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 16,751 | ||
| Daily Balance Of Power | (0.67) | ||
| Rate Of Daily Change | 0.92 | ||
| Day Median Price | 0.76 | ||
| Day Typical Price | 0.74 | ||
| Price Action Indicator | (0.07) |
Complementary Tools for PharmaCyte Stock analysis
When running PharmaCyte Biotech's price analysis, check to measure PharmaCyte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaCyte Biotech is operating at the current time. Most of PharmaCyte Biotech's value examination focuses on studying past and present price action to predict the probability of PharmaCyte Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaCyte Biotech's price. Additionally, you may evaluate how the addition of PharmaCyte Biotech to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |